STOCK TITAN

[Form 4] Cardlytics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Nick Lynton, Chief Legal & Privacy Officer of Cardlytics, Inc. (CDLX), reported multiple vesting and a sale related to restricted stock units. On 10/01/2025 the reporting person had 10,630, 581 and 1,578 RSUs treated as acquired (each converts into one share) and those awards increased their reported beneficial ownership to 122,425 shares before a sale. On 10/02/2025 the reporting person sold 6,098 shares at a weighted average price of $2.271 (individual sale prices ranged $2.21–$2.36) and the filing shows 116,327 shares owned after the sale. The filing states the sale was made solely to satisfy tax withholding from RSU vesting and discloses original grant sizes and vesting schedules for each RSU award.

Nick Lynton, Chief Legal & Privacy Officer di Cardlytics, Inc. (CDLX), ha riportato multiple vesting e una vendita relative a unità di azioni restritte (RSU). Il 10/01/2025 la persona reportante aveva 10.630, 581 e 1.578 RSU considerate acquisite (ognuna si converte in una azione) e tali premi hanno aumentato la proprietà beneficiaria riportata a 122.425 azioni prima della vendita. Il 10/02/2025 la persona reportante ha venduto 6.098 azioni a un prezzo medio ponderato di $2.271 (i prezzi di vendita individuali variavano tra $2.21–$2.36) e la documentazione mostra 116.327 azioni possedute dopo la vendita. La dichiarazione afferma che la vendita è stata effettuata esclusivamente per soddisfare le ritenute fiscali derivanti dal vesting delle RSU e rende note le dimensioni origini delle assegnazioni e i calendari di vesting per ogni premio RSU.

Nick Lynton, Director Jurídico y de Privacidad de Cardlytics, Inc. (CDLX), informó de múltiples vesting y una venta relacionada con unidades de acciones restringidas (RSU). El 01/10/2025 la persona que reporta tenía 10.630, 581 y 1.578 RSU consideradas adquiridas (cada una se convierte en una acción) y esas adjudicaciones aumentaron su propiedad beneficiaria reportada a 122.425 acciones antes de la venta. El 02/10/2025 la persona reportante vendió 6.098 acciones a un precio medio ponderado de $2.271 (los precios de venta individuales variaban entre $2.21–$2.36) y el archivo muestra 116.327 acciones poseídas tras la venta. El documento señala que la venta se realizó únicamente para satisfacer las retenciones fiscales por vesting de RSU y divulga los montos originales de las adjudicaciones y los calendarios de vesting para cada RSU.

닉 링턴, 카드릴틱스(Cardlytics), Inc. (CDLX)의 최고 법률 및 프라이버시 책임자(Chief Legal & Privacy Officer)가 제한주식단위(RSU)의 다수의 가득권 행사 및 매도를 보고했습니다. 2025-10-01에 보고자에게는 10,630, 5811,578 RSU가 취득으로 간주되었고(각각 한 주식으로 전환) 그 보상들이 보고된 지배적 소유를 매도 전 122,425 주로 증가시켰습니다. 2025-10-02에 보고자는 6,098 주를 가중평균가 $2.271로 매도했고(개별 매도 가격은 $2.21–$2.36 범위였으며) 신고서에 매도 후 보유 주식은 116,327 주로 기재되어 있습니다. 신고서는 매도가 RSU의 vesting으로 인한 세금 원천징수를 충족하기 위해서만 이뤄졌다고 밝히고 각 RSU 보상에 대한 원래 부여 규모와 vesting 일정도 공개합니다.

Nick Lynton, Directeur juridique et de la confidentialité de Cardlytics, Inc. (CDLX), a rendu compte de plusieurs périodes d'acquisition et d'une vente liées à des unités d'actions restreintes (RSU). Le 01/10/2025, la personne déclarant détenait 10 630, 581 et 1 578 RSU considérées comme acquises (chaque RSU se convertit en une action) et ces attributions ont porté la propriété bénéficiaire déclarée à 122 425 actions avant la vente. Le 02/10/2025, la personne déclarant a vendu 6 098 actions à un prix moyen pondéré de $2.271 (les prix de vente individuels variaient entre $2,21–$2,36) et le dossier indique 116 327 actions détenues après la vente. Le dossier précise que la vente a été réalisée uniquement pour satisfaire les retenues fiscales liées à la vesting des RSU et divulgue les montants d'attribution initiaux et les calendriers de vesting pour chaque RSU.

Nick Lynton, Chief Legal & Privacy Officer von Cardlytics, Inc. (CDLX), meldete mehrere Vesting-Ereignisse und einen Verkauf im Zusammenhang mit Restricted Stock Units. Am 10/01/2025 hatte die meldende Person 10.630, 581 und 1.578 RSUs, die als erworben gelten (jeweils wandelt sich in eine Aktie um) und diese Awards erhöhten die gemeldete wirtschaftliche Eigentümerschaft vor dem Verkauf auf 122.425 Aktien. Am 10/02/2025 verkaufte die meldende Person 6.098 Aktien zu einem gewichteten Durchschnittspreis von $2.271 (Einzelverkaufspreise lagen zwischen $2.21–$2.36) und das Filing zeigt nach dem Verkauf 116.327 Aktien. Die Einreichung gibt an, dass der Verkauf ausschließlich zur Begleichung der Steuern aus RSU-Vesting erfolgt sei und offenbart die ursprünglichen Grant-Größen und Vesting-Pläne für jeden RSU-Award.

Nick Lynton، الرئيس القانوني والمسؤول عن الخصوصية في Cardlytics, Inc. (CDLX)، أبلغ عن عدة فترات vesting وبيع متعلق بوحدات الأسهم المقيدة (RSU). في 10/01/2025 كانت لدى الشخص المبلغ عنه 10,630 و581 و1,578 RSU محسوبة كالمكتسبة (كل منها يتحول إلى سهم واحد) وارتفعت بذلك الملكية المستفيدة المعلنة إلى 122,425 سهمًا قبل البيع. في 10/02/2025 باع الشخص المبلغ عنه 6,098 أسهم بسعر متوسط مُثقل قدره $2.271 (أسعار البيع الفردية تراوحت بين $2.21–$2.36) وتوضح الوثيقة أن الملكية بعد البيع هي 116,327 سهمًا. تنص الوثيقة على أن البيع تم فقط لتلبية احتجاز الضرائب الناتج عن vesting RSU وتكشف عن أحجام المنح الأصلية وجداول vesting لكل جائزة RSU.

Nick Lynton,Cardlytics, Inc.(CDLX)的 首席法务官与隐私官报告了多项归属及与受限股票单位(RSU)相关的出售。于 2025/10/01,汇报人拥有 10,6305811,578 个 RSU,视为已取得(每个将转换为一股),这些奖励使其报导的实际控制权在出售前增至 122,425 股。于 2025/10/02,汇报人出售了 6,098 股,成交的加权平均价为 $2.271(单笔成交价区间为 $2.21–$2.36),备案显示出售后拥有股数为 116,327 股。备案指出,出售仅为满足 RSU 成 vesting 时的税务代扣,并披露每个 RSU 授予的原始规模和 vesting 计划。

Positive
  • 10,630 RSUs vested (converted to shares), reflecting awarded equity retention
  • Filing discloses detailed vesting schedules for RSU awards, clarifying future equity vesting timing
Negative
  • Sale of 6,098 shares reduced beneficial ownership to 116,327
  • Shares sold at a weighted average price of $2.271, within a range of $2.21–$2.36

Insights

Insider reported RSU vesting and a tax-related sale, reducing holdings to 116,327 shares.

The Form 4 documents conversion of multiple RSU awards on 10/01/2025, increasing pre-sale beneficial ownership to 122,425 shares. The filing then records a sale of 6,098 shares on 10/02/2025 at a weighted average price of $2.271.

This transaction is disclosed as a tax-withholding sale tied to RSU vesting; such sales are routine for employees and do not indicate opportunistic selling beyond withholding needs. The form also lists original award sizes and vesting schedules, which clarify ongoing equity-based compensation and retention mechanics.

Nick Lynton, Chief Legal & Privacy Officer di Cardlytics, Inc. (CDLX), ha riportato multiple vesting e una vendita relative a unità di azioni restritte (RSU). Il 10/01/2025 la persona reportante aveva 10.630, 581 e 1.578 RSU considerate acquisite (ognuna si converte in una azione) e tali premi hanno aumentato la proprietà beneficiaria riportata a 122.425 azioni prima della vendita. Il 10/02/2025 la persona reportante ha venduto 6.098 azioni a un prezzo medio ponderato di $2.271 (i prezzi di vendita individuali variavano tra $2.21–$2.36) e la documentazione mostra 116.327 azioni possedute dopo la vendita. La dichiarazione afferma che la vendita è stata effettuata esclusivamente per soddisfare le ritenute fiscali derivanti dal vesting delle RSU e rende note le dimensioni origini delle assegnazioni e i calendari di vesting per ogni premio RSU.

Nick Lynton, Director Jurídico y de Privacidad de Cardlytics, Inc. (CDLX), informó de múltiples vesting y una venta relacionada con unidades de acciones restringidas (RSU). El 01/10/2025 la persona que reporta tenía 10.630, 581 y 1.578 RSU consideradas adquiridas (cada una se convierte en una acción) y esas adjudicaciones aumentaron su propiedad beneficiaria reportada a 122.425 acciones antes de la venta. El 02/10/2025 la persona reportante vendió 6.098 acciones a un precio medio ponderado de $2.271 (los precios de venta individuales variaban entre $2.21–$2.36) y el archivo muestra 116.327 acciones poseídas tras la venta. El documento señala que la venta se realizó únicamente para satisfacer las retenciones fiscales por vesting de RSU y divulga los montos originales de las adjudicaciones y los calendarios de vesting para cada RSU.

닉 링턴, 카드릴틱스(Cardlytics), Inc. (CDLX)의 최고 법률 및 프라이버시 책임자(Chief Legal & Privacy Officer)가 제한주식단위(RSU)의 다수의 가득권 행사 및 매도를 보고했습니다. 2025-10-01에 보고자에게는 10,630, 5811,578 RSU가 취득으로 간주되었고(각각 한 주식으로 전환) 그 보상들이 보고된 지배적 소유를 매도 전 122,425 주로 증가시켰습니다. 2025-10-02에 보고자는 6,098 주를 가중평균가 $2.271로 매도했고(개별 매도 가격은 $2.21–$2.36 범위였으며) 신고서에 매도 후 보유 주식은 116,327 주로 기재되어 있습니다. 신고서는 매도가 RSU의 vesting으로 인한 세금 원천징수를 충족하기 위해서만 이뤄졌다고 밝히고 각 RSU 보상에 대한 원래 부여 규모와 vesting 일정도 공개합니다.

Nick Lynton, Directeur juridique et de la confidentialité de Cardlytics, Inc. (CDLX), a rendu compte de plusieurs périodes d'acquisition et d'une vente liées à des unités d'actions restreintes (RSU). Le 01/10/2025, la personne déclarant détenait 10 630, 581 et 1 578 RSU considérées comme acquises (chaque RSU se convertit en une action) et ces attributions ont porté la propriété bénéficiaire déclarée à 122 425 actions avant la vente. Le 02/10/2025, la personne déclarant a vendu 6 098 actions à un prix moyen pondéré de $2.271 (les prix de vente individuels variaient entre $2,21–$2,36) et le dossier indique 116 327 actions détenues après la vente. Le dossier précise que la vente a été réalisée uniquement pour satisfaire les retenues fiscales liées à la vesting des RSU et divulgue les montants d'attribution initiaux et les calendriers de vesting pour chaque RSU.

Nick Lynton, Chief Legal & Privacy Officer von Cardlytics, Inc. (CDLX), meldete mehrere Vesting-Ereignisse und einen Verkauf im Zusammenhang mit Restricted Stock Units. Am 10/01/2025 hatte die meldende Person 10.630, 581 und 1.578 RSUs, die als erworben gelten (jeweils wandelt sich in eine Aktie um) und diese Awards erhöhten die gemeldete wirtschaftliche Eigentümerschaft vor dem Verkauf auf 122.425 Aktien. Am 10/02/2025 verkaufte die meldende Person 6.098 Aktien zu einem gewichteten Durchschnittspreis von $2.271 (Einzelverkaufspreise lagen zwischen $2.21–$2.36) und das Filing zeigt nach dem Verkauf 116.327 Aktien. Die Einreichung gibt an, dass der Verkauf ausschließlich zur Begleichung der Steuern aus RSU-Vesting erfolgt sei und offenbart die ursprünglichen Grant-Größen und Vesting-Pläne für jeden RSU-Award.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Lynton Nicholas Hollmeyer

(Last) (First) (Middle)
675 PONCE DE LEON AVENUE NE
SUITE 4100

(Street)
ATLANTA GA 30308

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cardlytics, Inc. [ CDLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal & Privacy Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 M 10,630 A (1) 120,266 D
Common Stock 10/01/2025 M 581 A (1) 120,847 D
Common Stock 10/01/2025 M 1,578 A (1) 122,425 D
Common Stock 10/02/2025 S 6,098(2) D $2.271(3) 116,327 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 10/01/2025 M 10,630 (4) (4) Common Stock 10,630 $0 21,259 D
Restricted Stock Unit (1) 10/01/2025 M 581 (5) (5) Common Stock 581 $0 1,163 D
Restricted Stock Units (1) 10/01/2025 M 1,578 (6) (6) Common Stock 1,578 $0 4,734 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") and performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2025. The Reporting Person did not sell shares for any other purpose.
3. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
4. The RSU award was originally for 85,035 shares. The RSU award vested or will vest in eight equal installments on July 1, 2024, October 1, 2024, January 1, 2025, April 1, 2025, July 1, 2025, October 1, 2025, January 1, 2026 and April 1, 2026, provided that the Reporting Person remains employed by the Issuer on such vesting date.
5. The RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
6. This RSU award was originally for 25,247 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
Remarks:
/s/ Nick Lynton 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cardlytics insider Nick Lynton report on Form 4 (CDLX)?

The Form 4 reports RSU vesting on 10/01/2025 and a sale of 6,098 shares on 10/02/2025, leaving 116,327 shares beneficially owned.

Why were 6,098 shares sold by the reporting person?

The shares were sold solely to satisfy tax withholding obligations resulting from RSU delivery that vested on 10/01/2025.

At what price were the shares sold?

The weighted average sales price was $2.271; individual sale prices ranged from $2.21 to $2.36.

How many RSUs vested and what is their conversion?

The filing shows RSU/PSU awards of 10,630, 581, and 1,578; each unit represents a contingent right to receive one share of common stock.

What are the vesting schedules disclosed?

One award of 85,035 RSUs vests in eight equal installments through April 1, 2026; other awards vest 25% initially with the remainder vesting quarterly over three years as stated.
Cardlytics

NASDAQ:CDLX

CDLX Rankings

CDLX Latest News

CDLX Latest SEC Filings

CDLX Stock Data

126.17M
51.67M
2.95%
45.79%
14.27%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
Link
United States
ATLANTA